SCHEMBL8285232

SCHEMBL8285232

Cc1cc(C(O)c2ccc(Cl)cc2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.43
GAA P10253 4/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 5/20 0.37
LMNA P02545 3/20 0.37
HTT P42858 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
ALPG P10696 1/20 0.35
POLB P06746 1/20 0.34
MAPK1 P28482 2/20 0.34
MAT2A P31153 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
JUN P05412 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287116 0.83 PDE11A (0.48) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8285175 0.82 PDE11A (0.44) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8285183 0.82 PDE11A (0.41) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8287388 0.81 MAPT (0.48) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL5871751 0.81 PDE11A (0.48) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8285205 0.80 MAPT (0.44) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8287142 0.79 PDE11A (0.44) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL5871799 0.78 PDE11A (0.50) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8285163 0.78 POLB (0.50) PDE11AGAAHPGDSMN1; SMN2MAPT
SCHEMBL8287393 0.77 PDE11A (0.46) PDE11AHPGDSMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed